30
Aug 2026
Sexual health education empowers young people to prevent infections
For many adolescents and young adults, life revolves around new experiences, greater independence, and new relationships.
Stay Informed!
30
Aug 2026
TAVI-first strategy proves noninferior to PCI-first approach in new trial
A TAVI-first strategy was noninferior to a PCI-first strategy after one years' follow-up, according to results presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.
30
Aug 2026
Does a psychedelic need an awake brain to have lasting effects? This mouse study offers a clue
A single dose of psilocybin produced a lasting increase in sociability for at least two weeks in Cntnap2-knockout mice with social deficits, while it did not enhance sociability overall in mice with normal social behavior. The effect required 5-HT2A receptor activation and persisted when psilocybin was administered under light anesthesia, suggesting that wakefulness during the drug’s acute effects was not necessary for this behavioral response.
30
Aug 2026
Starting statins early after diabetes diagnosis linked to lower dementia risk
Early initiation of statins after diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study presented today at ESC Congress 2026 and published in The Lancet Regional Health – Europe.
30
Aug 2026
Oral relaxin agonist AZD5462 improves cardiac function in heart failure patients
The oral relaxin agonist, AZD5462, improved cardiac function in patients with chronic heart failure, according to results presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in Circulation.
30
Aug 2026
Met-HeFT trial finds no cardiovascular benefit from metformin
Metformin did not significantly affect the risk of cardiovascular outcomes in patients with heart failure with reduced ejection fraction and diabetes or at risk of diabetes.
30
Aug 2026
H-ISDN shows no significant benefit in broader heart failure population
In patients with heart failure, hydralazine with isosorbide dinitrate did not significantly improve the incidence of death or heart failure events and treatment discontinuation rates were high.
30
Aug 2026
People with diabetes may have another reason to protect their cardiovascular health
Better cardiovascular health, measured using Life’s Essential 8, was associated with a lower risk of mild cognitive impairment among people with diabetes after accounting for genetic susceptibility. Associations with dementia varied by genetic risk, while higher LE8 scores were also linked to greater gray matter volume and lower white matter hyperintensity volume.
30
Aug 2026
Your skin may offer clues about how many fruits and vegetables you eat
In an exploratory study of 137 Australian adults, skin yellowness measured by reflectance spectroscopy was associated with combined fruit and vegetable intake, fruit intake alone, total carotenoid intake, body fat percentage and skin color. The findings suggest skin measurements could provide an objective dietary biomarker, but the researchers caution that skin color, ethnicity and other individual characteristics may influence how the measurements are interpreted.
30
Aug 2026
Breast cancer survivors could avoid lifelong heart medication, research suggests
Many breast cancer survivors whose treatment caused them to develop problems with their heart function can safely stop their medication after their heart recovers and most won't need to continue treatment long-term, according to a study funded by the British Heart Foundation and presented at the European Society of Cardiology Congress in Munich.
